Fresh money, milestones in the clinical development of novel drugs and medical products, new agreements and press releases about seminal new infrastructures such as a CD lab or a new proteomics facility are included. Additionally, a preview of the international professional events LISAvienna will soon participate in, is enclosed. Also make a note of the upcoming funding deadlines we remind of. In this regard, also make use of our webpage as a resources for your searches and consider the Horizon2020 calls published end of July.
In our e-newsletter, you will also find a link to a new article that has been written in the context of our collaboration with Chemiereport. It focuses on novel cancer therapeutics made in Vienna.